Krintafel Dosage
Generic name: TAFENOQUINE SUCCINATE 150mg
Dosage form: tablet, film coated
Drug class: Antimalarial quinolines
Medically reviewed by Drugs.com. Last updated on Aug 2, 2023.
Tests to be Performed Prior to Treatment with KRINTAFEL
All patients must be tested for glucose-6-phosphate dehydrogenase (G6PD) deficiency prior to prescribing KRINTAFEL [see Contraindications (4), Warnings and Precautions (5.1)].
Pregnancy testing is recommended for females of reproductive potential prior to initiating treatment with KRINTAFEL [see Use in Specific Populations (8.1, 8.3)].
Recommended Dosage and Administration
The recommended dose of KRINTAFEL in patients aged 16 years and older is a single dose of 300 mg administered as two 150-mg tablets taken together. Coadminister KRINTAFEL on the first or second day of chloroquine therapy for acute P. vivax malaria [see Clinical Studies (14)].
Administer KRINTAFEL with food to increase systemic absorption [see Clinical Pharmacology (12.3)].
Swallow tablets whole. Do not break, crush, or chew the tablets.
In the event of vomiting within 1 hour after dosing, a repeat dose should be given. Re-dosing should not be attempted more than once.
Frequently asked questions
- What is the difference between Arakoda and Krintafel?
- How do you take Krintafel?
- How do you take Arakoda for the prevention of malaria?
More about Krintafel (tafenoquine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- During pregnancy
- FDA approval history
- Drug class: antimalarial quinolines
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
